REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Fortis Pharmaceuticals Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: All Other Food Manufacturing | All Other Miscellaneous Food Manufacturing | Pharmaceutical Preparation Manufacturing | Chemical and Allied Products Merchant Wholesalers | Wholesale Trade Agents and Brokers | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Fortis Pharmaceuticals Sp. z o.o. Profile Updated: April 09, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Fortis Pharmaceuticals Sp. z o.o. is based in Poland, with the head office in Katowice. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. Fortis Pharmaceuticals Sp. z o.o. was incorporated on September 16, 2021. 101 - 500 (2024) employees currently work for Fortis Pharmaceuticals Sp. z o.o.. From the latest financial highlights, Fortis Pharmaceuticals Sp. z o.o. reported a net sales revenue increase of 29.31% in 2023. Over the same period, its total assets grew by 18.41%. The net profit margin of Fortis Pharmaceuticals Sp. z o.o. increased by 4.25% in 2023.

Headquarters
Ul. Adama Mickiewicza 29
Katowice; Slaskie; Postal Code: 40-085

Contact Details: Purchase the Fortis Pharmaceuticals Sp. z o.o. report to view the information.

Website: http://www.fortispharmaceuticals.pl

Basic Information
Total Employees:
Purchase the Fortis Pharmaceuticals Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Fortis Pharmaceuticals Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Fortis Pharmaceuticals Sp. z o.o. report to view the information.
Incorporation Date:
September 16, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Fortis Pharmaceuticals Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
29.31%▲
Total Operating Revenue
34.65%▲
Operating Profit
58.76%▲
EBITDA
55.74%▲
Net Profit/Loss for the Period
102.94%▲
Total Assets
18.41%▲
Total Equity
129.92%▲
Operating Profit Margin
2.37%▲
Net Profit Margin
4.25%▲
Return on Equity (ROE)
-7.51%▼
Debt / Equity
-74%▼
Quick Ratio
0.15%▲

Similar companies

Eurocash S.A.
 
AB S.A.
Neuca S.A.
 
Pepco Poland Sp. z o.o.
Samsung Electronics Polska Sp. z o.o.
 
Polska Grupa Farmaceutyczna S.A.
Firma Produkcyjno Handlowa Srubres R.Krauz T.Rzeznik sp. j.
 
Chatler Parfume Sp. z o.o.
Apra Product Sp. z o.o.
 
Pharma Trading Sp. z o.o.
Wurga Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo